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Cochlear implantation has become established worldwide as a safe and effective method of auditory
rehabilitation of selected severely and profound deaf children and adults. Over 100,000 patients have received
cochlear implants worldwide with the paediatric population proving to be the main beneficiaries. The Libyan
cochlear implant programme was set up in 2004. Data relating to the patients who received cochlear
implantation at Tripoli Medical Centre between October 2007 and February 2010 were analysed. Implant
operations were performed on 37 patients. All patients received Med-El SONATATI
100 devices. Thirty-four
(91.9%) of these patients were children, whilst three (8.1%) were adults. Combined, congenital hearing loss
(56.8%) and perinatal/neonatal (29.7%) were the two main aetiological factors in children. Seventeen patients
(45.9%) had a positive family history of deafness. Sixteen patients (43.2%) were born to blood-related parents.
The overall rate of minor and major complications was 16.2%, which is comparable to previous studies.
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C
ochlear implantation (CI) has become established
worldwide as a safe and effective intervention for
auditory rehabilitation of selected severely and
profound deaf children and adults with sensorineural
hearing loss (1, 2). Cochlear implantation allows the
implant beneficiary to reintegrate with the hearing world
(3). Its value, safety, and dependability are well docu-
mented (1). It is estimated that over 100,000 patients have
received cochlear implants worldwide with the paediatric
population proving to be the main beneficiaries from this
prosthesis (1, 3). Studies have revealed that the majority
of CI users, affected by pre- or post-lingual deafness,
acquire considerable benefit from this intervention (4).
Cochlear implantation is currently the only means of
restoring a sufficient level of hearing in patients with
severe to profound hearing impairment that are not
remedied by conventional methods such as hearing aids
(5). All these factors make cochlear implantation argu-
ably the most successful neural prosthesis in the history
of medicine.
The aim of a cochlear implant is to replace a non-
functional inner ear hair cell transducer system by
converting mechanical sound energy into electrical sig-
nals that can be delivered to the cochlear nerve in
profoundly deaf patients (6). The cochlear implant device
is comprised of a number of components that include (5):
a microphone, which picks up acoustic information and
converts them into electrical signals; an externally worn
speech device that processes the signal according to a
predefined strategy; and a surgically implanted electrode
array that is in the cochlea near the auditory nerve.
Essentially, the aim of a cochlear implant is to provide
direct stimulation of the spiral ganglion cells of
the cochlear nerve bypassing the damaged hair cells (6).
Libya is a developing North African country with an
estimated population of 5,323,991 (7). Tripoli is the
capital city of Libya situated on the northwest coastline
of the country. Tripoli Medical Centre (TMC) is a public
hospital with about 1,450 beds, 1,000 physicians, and
approximately 3,000 employees. The hospital provides its
services to a significant proportion of the population. In
addition to the inhabitants of Tripoli, patients from
across Libya present to TMC due to its level of expertise,
facilities, and provision of care. Tripoli Medical Centre is
the sole institution in Libya that installs cochlear
implants.
The Libyan cochlear implant programme (LCIP) was
set up in 2004. Prior to the development of the
programme, patients predominantly travelled to Europe
as well as neighbouring Arab countries such as Egypt and
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substantial financial implications of medical care and
travelling among many other factors, very few patients
could afford the costs of surgery, aftercare, and rehabi-
litation.
Tripoli Medical Centre is recognised as the official
cochlear implant centre. However, other ENT depart-
ments in Libya have offered this procedure mainly to be
carried out by visiting surgeons from across the world.
Data relating to these procedures and patient profiles of
those implanted outside TMC, although very few, are
unfortunately unknown and have not been included in
this report. The aim of this report is to describe the
experiences and progress of the cochlear implant in
Libya.
Methods
Data relating to patients who received cochlear implanta-
tion between October 2007 and February 2010 were
studied. Implant operations were performed on 37
patients. Patient records available at the time of the study
includes age of patient at implantation, year of implanta-
tion, place of birth, diagnosis leading to hearing loss,
perinatal, neonatal and medical history, pre-operative
investigations (Computed Tomography [CT] and Mag-
netic Resonance Imaging [MRI]), pre-operative audio-
metry tests, and any post-operative complications. The
LCIP currently accepts the minimum age for implanta-
tion of 2 years for anatomical reasons.
Surgical approach
From the outset of the programme, the classical surgical
technique for cochlear implantation has been used on all
patients. The main steps in this approach include a post-
auricular ‘C’ shaped incision usually made 1 cm from the
planned site of the receiver (Fig. 1). The pericranium is
raised with the skin flap in order to maintain good
vascular supply, as mentioned in previous studies (4).
Afterwards, a cortical mastoidectomy is performed and a
bed (bony well) is drilled for the receiver-stimulator unit
(8). Posterior tympanotomy is then carried out, followed
by cochleostomy, which has been enthusiastically
adopted by cochlear implant surgeons as it provides
good access to the round window and promontory (9).
Care and precision is taken not to mistake hypotympanic
cells for the round window niche in order to correctly
insert the electrode array in the scala tympani, in order to
prevent what is considered an unacceptable complication
(4). The duration of this operation usually lasts up to
2 hours. All paediatric patients were given intra- and
post-operative prophylactic antibiotics (ceftriaxone)
against meningitis.
Results
Since 2007, a total of 37 implantations have been
performed through the LCIP. Four of these operations
(10.8%) were performed in 2007, 12 (32.4%) in 2008, 19
(51.4%) in 2009, and 2 (5.4%) up until February 2010. All
patients received MED-EL SONATATI
100 devices. Post-
operative switch on was performed 4 weeks post-im-
plantation. Each patient taking part in the LCIP was
given a specialist auditory and communication skills
training that was incorporated in their rehabilitation
programme at TMC.
Thirty-four (91.9%) of these patients were children
(male, 19; female, 15). Three adults (8.1%) were installed
with implants, of which two were male and one female.
Thirty-two (86.5%) patients received implants in their
right ear, whilst five (13.5%) patients were implanted in
their left ear. Seventeen (45.9%) patients received co-
chlear implants before the age of five. Of this subgroup,
nine (52.9%) were male and eight (47.1%) were female.
The mean age of paediatric patients taking part in the
programme was 3.4 years (Fig. 2).
The study revealed that 21 (56.8%) patients presented
with congenital hearing loss as the primary aetiology of
their deafness (Table 1). Other aetiologies included
meningitis, progressive disease, and perinatal/neonatal
(including prematurity, pre-eclampsia, birth asphyxia,
meconium aspiration, and febrile convulsions). Thirty-
five patients (94.6%) presenting to the programme were
Fig. 1. Post-auricular incision performed with a view of the
cochlear implant (Courtesy of Dr Anwer Esriti).
Table 1. Aetiology of hearing loss
Aetiology No. (%)
Congenital 21 (56.8%)
Progressive 3 (8.1%)
Meningitis 2 (5.4%)
Perinatal/neonatal 11 (29.7%)
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patients (5.4%) that were diagnosed with auditory
neuropathy were referred for cochlear implantation and
will be discussed further on in this study.
Three patients taking part in the programme were
adults. One patient had a cerebrovascular accident that
led to deterioration in hearing and as a result was
installed with a cochlear implant. This patient unfortu-
nately died a number of months after being implanted,
the cause of which was not linked to the surgery. The
other two patients had progressive aetiologies causing
their profound hearing loss. Both remaining adult
patients underwent intensive auditory post-implantation
and have since integrated well into society and are
content with the results of the implant. Both patients
have reported no complications.
Records of each patient hearing thresholds were also
reviewed (Fig. 3). As classified by the WHO, all patients
were identified as having profound hearing impairment
(81 dB or greater in better ear). Eighteen patients (48.7%)
were recorded having an ABR up to 90 dB, 14 (37.8%)
with ABR of up to 100 dB, 4 (10.8%) up to 105 dB, and
1 patient with an ABR of up to 110 dB (Fig. 3). Three
post-lingual patients, all of whom were adults, were tested
by tympanometry. Two patient’s otoacoustic emissions
were identified, in addition to their abnormal ABR and
hence were given a diagnosis of auditory neuropathy.
Data collected in this study also includes the home-
town of each patient. Fourteen patients (37.8%) presented
from Tripoli; four patients (10.8%) each from Benghazi
and Al-Zawya; two patients (5.4%) each from Al-Bayda,
Kikla, Ghriyan, Misrata and Subrata; and a patient
(2.7%) each from Al-Azizia, Ghat, Al-Zahra, Mselata,
and Zletan. The hypothesis of geographical factors
influencing deafness will be reviewed in the discussion
section of this paper.
Seventeen patients (45.9%) had a positive history of
deafness in the family (a first degree relative suffering
from deafness). Sixteen patients (43.2%) had blood-
related parents, 13 had parents whom were first degree
cousins (35.1%), 1 patient (2.7%) whose parents were
second degree cousins, and 2 patients (5.4%) whom
parents were third degree cousins. Twenty-one patients
(56.8%) had parents whom were not related (Table 2).
Of the 17 patients with a family history of deafness,
11 patients (64.7%) had parents related to the first degree,
2 (11.8%) with third degree related parents, and 4 patients
(23.5%) with parents not blood related. While in com-
parison, patients with a negative family history of deaf-
ness, 2 patients (10%) had parents related to the first
degree, 1 (5%) with second degree related parents, and
17 patients (85%) with parents not blood related.
Cochlear implantation has been recognised as a safe
intervention (1, 3). However, as with any type of surgery,
it possesses the risk of minor and major complications
(2). A major complication is defined as one leading to
explantation or re-implantation, death of a patient, or
stay in hospital in excess of 1 week. A minor complication
is defined as self-limiting or improves with conservative
management (2, 3).
The overall incidence of post-operative complications
was 16.2%. There were minor complications in three
patients (8.1%), all of whom had a haematoma surround-
ing the implant occurring within the first week of surgery.
Fig. 2. Age and gender of patient at implantation.
Fig. 3. Pre-operative hearing thresholds.
Table 2. Consanguinity, family history, and parent blood
relation
Consanguinuity
Family history 1st degree 2nd degree 3rd degree None
ve (n17) 11 (64.7%) 0 (0%) 2 (11.8%) 4 (23.5%)
ve (n20) 2 (10%) 1 (5%) 0 (0%) 17 (85%)
Total (n37) 13 (35.1%) 1 (2.7%) 2 (5.4%) 21 (56.8%)
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spontaneously, while the third patient had his haema-
toma aspirated and all recovered without incidence. Two
patients (5.4%) included in the study were re-implanted
due to damaged implants that were performed in 2004.
During the programme, only one patient (2.7%) devel-
oped CSF gusher, which is considered a major complica-
tion (Table 3). This complication was managed by
operating on the patient again and occluding the
Eustachian tube and the cochleostomy site. After this
intervention, the patient recovered well.
Two patients were installed with cochlear implants in
spite of their diagnosis of auditory neuropathy. This
phenomenon is a sensorineural hearing disorder distin-
guished by an abnormal/absent ABR in spite of a present
otoacoustic emission (10, 11). The matter of installing
cochlear implants in patients with auditory neuropathy is
still a contentious one and is currently being hotly
debated. However, there are promising signs as demon-
strated by a previous study (12), which suggests that the
outcome of implanting patients with auditory neuropathy
does not differ drastically from their paediatric counter-
parts with sensorineural hearing loss. Previous studies
hypothesise that the cochlear implant is able to overcome
the theory of principal desynchronisation as thought with
auditory neuropathy (12).
Discussion
Previous data (3) has reported cases of meningitis post-
implantation. As a result, all paediatric patients were
given intra-andpost-operativeceftriaxone.Post-operative
meningitis was not observed in any of the LCIP patients.
The majority of implanted patients were children (91.9%)
and their mean age at implantation was 3.4 years. There
were 56.8% patients that presented with congenital hear-
ing loss, which is comparable to other reports (3). The
incidence of sensorineural hearing loss among children in
Libya until today is still unknown and requires further
research.
Until now, there has been no study identifying
geography as a cause or an influence on the aetiology
of deafness. The remote location of some patients and the
distances travelled by these patients to reach Tripoli is
remarkable. One of the main criteria in selecting patients
for the LCIP was their commitment to rehabilitation
post-operatively.
Due to financial implications associated with develop-
ing a cochlear implant programme in a developing
country, post-operative hearing testing was very limited.
Currently, a post-operative x-ray is performed to identify
the location of the implant as well. Ideally, the assessment
of speech and language development post-implantation
include hearing threshold levels, measured by pure tone
audiograms as well as listening progress profiles. How-
ever, due to a lack of funds, politics and the LCIP being a
relatively new cochlear programme, these forms of
monitoring after implantation were neither available
nor correctly recorded to be added to this study.
A number of studies have shown that excellent results
are feasible as well as achievable in pre-lingual patients
when a cochlear implant is received before the age of
three without surgical complications or functional tuning
difficulties (3, 6, 8). The desired aim of the LCIP, as well
as other cochlear programmes, is to implant younger pre-
lingual children as soon as possible, eventually even
during the first year of life from a neuro-developmental
point of view (6). In reality this concept, however, is
dependent on a number of factors for it to succeed in
Libya.
Initially, early identification of high risk patients is
necessary, particularly patients with a positive family
history. Extensive media coverage of the programme on
local television has encouragingly raised awareness and
provided great exposure to the public about hearing loss
and the cochlear implant programme among the general
public. This issue has so far been dealt with well in Libya,
ever since the introduction of the LCIP.
Firstly, this has led to earlier presentation of patients
with a complaint of hearing loss. Secondly, this has
lowered the thresholds of families in coming forward with
their children with delayed hearing development. Thirdly,
it has given members of the multi-disciplinary team an
opportunity to intervene at an earlier stage and offer their
services and recommend rehabilitation sooner than what
was previously possible.
Neonatal screening of hearing loss until now has yet to
be formally initiated in Libya. The matter of screening is
multi-factorial and is dependent on a number of issues.
Firstly, government funding and backing is required to
set up a successful screening process. Secondly, a more
intensive and interactive campaigning with the general
population about hearing loss are needed for quicker
presentation. Hopefully, this will eventually take in the
form of genetic counselling of blood-related parents and
families with positive histories of hearing impairment.
As prevention is better than cure, it is a timely
opportunity for the obstetrics and neonatal services in
Libya to be reviewed. Perinatal and neonatal causes of
hearing loss appear to be prevalent in this study for some
reason or another. Eleven patients (29.7%) had history
relating to conditions such as birth asphyxia, meconium
Table 3. Number of complications
Complications No. (%)
None 31 (83.3%)
Haematoma 3 (8.1%)
Re-implantation 2 (5.4%)
CSF gusher 1 (2.7%)
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review of these services in Libya may help tackle what
may possibly be avoidable causes of hearing loss.
Inherited causes of hearing impairment are an im-
portant cause of severe and profound hearing loss (13).
Previous studies (14, 15) have revealed that 70% of cases
of severe hearing loss were the result of consanguineous
marriages (1). This study identified 16 patients (43.2%)
that were born to blood-related parents. Seventeen
patients (45.9%) had a positive family history of deafness.
Eleven of the 17 (64.7%) had parents blood related to the
first degree (Table 4). Although, perhaps not common in
the West, the practice of consanguineous marriages is
prevalent and frequent practice in many countries across
the world, especially in the Middle East and parts of Asia
for a number of social and cultural circumstances (1, 3,
14, 15). This custom makes tackling the topic of hearing
loss a bit harder. In spite of this, certain steps could be
taken in view of preventing hearing loss as much as
possible. Schemes such as health education, genetic
Table 4. Patient demographics
Patient Age Sex Ear DOI Aetiology FHx Consanguinity
1 3 F R 07/10/07 Premature  Third
2 4 M R 15/10/07 Pre-eclampsia 
3 4 M R 07/10/07 MA and FC  Second
4 52 M R 15/10/07 Progressive 
5 4 F R 20/01/08 Congenital 
6 7 F R 31/01/08 Congenital  First
7 3 M R 03/02/08 BA and MA 
8 3 M R 03/02/08 Congenital  First
9 5 F R 09/03/08 Congenital 
10 5 M R 23/03/08 Congenital 
11 3 M R 06/04/08 Congenital 
12 6 F R 08/04/08 Congenital  First
13 30 F L 04/05/08 Progressive 
14 4 M R 11/05/08 Congenital 
15 5 M R 28/12/08 Congenital 
16 5 F R 22/01/09 Congenital 
17 6 M L 08/02/09 Congenital  First
18 5 F L 09/02/08 FC  First
19 5 M R 10/02/09 FC 
20 6 M R 01/03/09 Congenital 
21 5 M R 11/03/09 BA 
22
a 5 M R 22/03/09 Congenital  First
23 4 M R 22/03/09 Meningitis  First
24 3 M R 12/04/09 BA and FC 
25 3 F R 19/04/09 Premature 
26 3 F R 10/05/09 Meningitis 
27 6 M R 31/05/09 Congenital 
28 4 F R 14/06/09 Congenital 
29 4 F R 17/06/09 FC 
30 6 M R 21/06/09 Congenital  First
31 3 F L 02/09/09 MA  Third
32 3 F R 06/09/09 Congenital  First
33 3 M R 09/09/09 Congenital  First
34
a 6 M R 13/09/09 Congenital  First
35 32 M L 02/12/09 Progressive 
36 5 F R 27/01/10 Congenital  First
37 5 F R 07/02/10 Congenital  First
adiagnosed with auditory neuropathy.
Note: FHx, family history; DOI, date of implantation; R, right; L, left; BA, birth asphyxia; MA, meconium aspiration; FC, febrile convulsions.
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munisation programmes and screening will all synergis-
tically benefit the citizens of Libya and its health service
in treating those with a hearing impairment.
Although all patients benefited greatly from their
implants, it is difficult to compare these results to other
studies, without the use of pure tone audiograms and
listening profiles. As a number of patients travel vast
distances to present to TMC, outreach programmes
could be offered and set up in a number of cities across
Libya in order to assess patients locally and intervene
sooner. Future research is required to identify the genetic
causes of hearing loss particularly in consanguineous
marriages and in those with a positive family history of
hearing impairment. Additionally, an appraisal of the
perinatal and neonatal services in Libya is needed to
review the high numbers of perinatal and neonatal
conditions leading to impaired hearing.
Conclusion
The LCIP has proved to be a successful rehabilitative
intervention for children and adults in the country so far.
Further government funding is required to continue the
progress already made and provide the means to improve
the existing programme. Future initiatives such as health
education, genetic counselling, adequate perinatal and
neonatal care, immunisation programmes, and screening
will all go a long way in preventing deafness, identify
those at risk, and allow earlier intervention of people
affected by a hearing impairment in Libya.
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